Integrin α1β1 and α2β1 Are the Key Regulators of Hepatocarcinoma Cell Invasion Across the Fibrotic Matrix Microenvironment

Cancer Research

Volumn 63, Issue 23, 2003, Pages 8312-8317

  Yang, Changqing ^a   Zeisberg, Michael ^a   Lively, Julie C ^a   Nyberg, Pia ^a   Afdhal, Nezam ^a   Kalluri, Raghu ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BLOCKING ANTIBODY; EPIDERMAL GROWTH FACTOR; GELATINASE A; GROWTH FACTOR; INTEGRIN; MATRIX METALLOPROTEINASE INHIBITOR; NEUTRALIZING ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1; VERY LATE ACTIVATION ANTIGEN 1; VERY LATE ACTIVATION ANTIGEN 2; GROWTH PROMOTOR; MATRIX METALLOPROTEINASE;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL INTERACTION; CELL MIGRATION; CELL MOTILITY; CELL STRAIN HEPG2; CHANG LIVER CELL; CHEMOTAXIS; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HAPTOTAXIS; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LIVER FIBROSIS; METASTASIS; MICROENVIRONMENT; PRIORITY JOURNAL; CELL MOTION; DRUG EFFECT; LIVER TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; EXTRACELLULAR MATRIX; GROWTH SUBSTANCES; HUMANS; INTEGRIN ALPHA1BETA1; INTEGRIN ALPHA2BETA1; LIVER NEOPLASMS; MATRIX METALLOPROTEINASES; NEOPLASM INVASIVENESS;

EID: 0346365371     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Kuper, H., Ye. W., Broome, U., Romelsjo, A., Mucci, L. A., Ekbom, A., Adami, H. O., Trichopoulos, D., and Nyren, O. The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis. Hepatology, 34: 714-718, 2001.
2. Tang, Z. Y. Hepatocellular carcinoma: cause, treatment and metastasis. World J. Gastroenterol., 7: 445-454, 2001.
3. Kew, M. C., and Popper, H. Relationship between hepatocellular carcinoma and cirrhosis. Semin. Liver Dis., 4: 136-146, 1984.
4. Lee, R. G., Tsamandas, A. C., and Demetris, A. J. Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: matched case-control study, pathological analysis, and pathogenetic hypothesis. Hepatology, 26: 1415-1422, 1997.
5. Qin, L. X., and Tang, Z. Y. The prognostic significance of clinical and pathological features in hepatocellular carcinoma. World J. Gastroenterol., 8: 193-199, 2002.
6. Hanahan, D., and Weinberg, R. A. The hallmarks of cancer. Cell, 100: 57-70, 2000.
7. Quaranta, V. Motility cues in the tumor microenvironment. Differentiation. 70: 590-598, 2002.
8. Ellis, L. M., and Fidler, I. J. Angiogenesis and metastasis. Eur. J. Cancer, 32A: 2451-2460, 1996.
9. Friedman, S. L. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol. Chem. 275: 2247-2250, 2000.
10. Yang, C., Zeisberg, M., Mosterman, B., Sudhakar, A., Yerramalla, U., Holthaus, K., Xu, L., Eng, F., Afdhal, N., and Kalluri, R. Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors. Gastroenterology, 124: 147-159, 2003.
11. Zeisberg, M., Bonner, G., Maeshima, Y., Colorado, P., Muller, G. A., Strutz, F., and Kalluri, R. Renal fibrosis: collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation. Am. J. Pathol., 159: 1313-1321, 2001.
12. Mutsaers, S. E., Bishop, J. E., McGrouther, G., and Laurent, G. J. Mechanisms of tissue repair: from wound healing to fibrosis. Int. J. Biochem. Cell Biol., 29: 5-17, 1997.
13. Bissell, D. M. Chronic liver injury, TGF-β, and cancer. Exp. Mol. Med., 33: 179-190, 2001.
14. Liotta, L. A., and Kohn, E. C. The microenvironment of the tumour-host interface. Nature (Lond.), 411: 375-379, 2001.
15. Fidler, I. J., Kumar, R., Bielenberg, D. R., and Ellis, L. M. Molecular determinants of angiogenesis in cancer metastasis. Cancer J. Sci. Am., 4 (Suppl. 1): S58-S66, 1998.
16. Kassis, J., Lauffenburger, D. A., Turner, T., and Wells, A. Tumor invasion as dysregulated cell motility. Semin. Cancer Biol., 11: 105-117, 2001.
17. Radisky, D., Hagios, C., and Bissell, M. J. Tumors are unique organs defined by abnormal signaling and context. Semin. Cancer Biol., 11: 87-95, 2001.
18. Egeblad, M., and Werb, Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer, 2: 161-174, 2002.
19. Stetler-Stevenson, W. G., Aznavoorian, S., and Liotta, L. A. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol., 9: 541-573, 1993.
20. Giannelli, G., Bergamini, C., Fransvea, E., Marinosci, F., Quaranta, V., and Antonaci, S. Human hepatocellular carcinoma (HCC) cells require both α3β1 integrin and matrix metalloproteinases activity for migration and invasion. Lab. Invest., 81: 613-627, 2001.
21. Giannelli, G., Fransvea, E., Marinosci, F., Bergamini, C., Colucci, S., Schiraldi, O., and Antonaci, S. Transforming growth factor-β1 triggers hepatocellular carcinoma invasiveness via α3β1 integrin. Am. J. Pathol., 161: 183-193, 2002.
22. Nejjari, M., Hafdi, Z., Dumortier, J., Bringuier, A. F., Feldmann, G., and Seoazee, J. Y. α6β1 Integrin expression in hepatocarcinoma cells: regulation and role in cell adhesion and migration. Int. J. Cancer, 83: 518-525, 1999.
23. Nejjari, M., Hafdi, Z., Gouysse, G., Fiorentino, M., Beatrix, O., Dumortier, J., Pourreyron, C., Barozzi, C., D'Errico, A., Grigioni, W. F., and Scoazec, J. Y. Expression, regulation, and function of αV integrins in hepatocellular carcinoma: an in vivo and in vitro study. Hepatology, 36: 418-426, 2002.
24. Rabinovitz, I., Gipson, I. K., and Mercurio, A. M. Traction forces mediated by α6β4 integrin: implications for basement membrane organization and tumor invasion. Mol. Biol. Cell, 12: 4030-4043, 2001.
25. Zeisberg, M., Maeshima, Y., Mosterman, B., and Kalluri, R. Renal fibrosis: extracellular matrix microenvironment regulates migratory behavior of activated tubular epithelial cells. Am. J. Pathol., 160: 2001-2008, 2002.
26. Cianfrocca, M., Cooley, T. P., Lee, J. Y., Rudek, M. A., Scadden, D. T., Ratner, L., Pluda, J. M., Figg, W. D., Krown, S. E., and Dezube, B. J. Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a Phase I AIDS malignancy consortium study. J. Clin. Oncol., 20: 153-159, 2002.
27. Carney, D. E., McCann, U. G., Schiller, H. J., Gatto, L. A., Steinberg, J., Picone, A. L., and Nieman, G. F. Metalloproteinase inhibition prevents acute respiratory distress syndrome. J. Surg. Res., 99: 245-252, 2001.
28. Werb, Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell, 91: 439-442, 1997.
29. Lochter, A., Sternlicht, M. D., Werb, Z., and Bissell, M. J. The significance of matrix metalloproteinases during early stages of tumor progression. Ann. N. Y. Acad. Sci., 857: 180-193, 1998.
30. Martinez-Hernandez, A., and Amenta, P. S. The extracellular matrix in hepatic regeneration. FASEB J., 9: 1401-1410, 1995.
31. Du, W. D., Zhang, Y. E., Zhai, W. R., and Zhou, X. M. Dynamic changes of type I, III and IV collagen synthesis and distribution of collagen-producing cells in carbon tetrachloride-induced rat liver fibrosis. World J. Gastroenterol., 5: 397-403, 1999.
32. Van Eyken, P., Geerts, A., De Bleser, P., Lazou, J. M., Vrijsen, R., Sciot, R., Wisse, E., and Desmet, V. J. Localization and cellular source of the extracellular matrix protein tenascin in normal and fibrotic rat liver. Hepatology, 15: 909-916, 1992.
33. Richter, H. B., Franke, H., and Dargel, R. Expression of tenascin, fibronectin, and laminin in rat liver fibrogenesis: a comparative immunohistochemical study with two models of liver injury. Exp. Toxicol. Pathol., 50: 315-322, 1998.
34. Torbenson, M., Wang, J., Choti, M., Ashfaq, R., Maitra, A., Wilentz, R. E., and Boitnott, J. Hepatocellular carcinomas show abnormal expression of fibronectin protein. Mod. Pathol., 15: 826-830, 2002.
35. Rutten, M. J., Dempsey, P. J., Luttropp, C. A., Hawkey, M. A., Sheppard, B. C., Crass, R. A., Deveney, C. W., and Coffey, R. J., Jr. Identification of an EGF/TGF-α receptor in primary cultures of guinea pig gastric mucous epithelial cells. Am. J. Physiol., 270: G604-G612, 1996.
36. Palmer, U., Liu, Z., Broome, U., and Klominek, J. Epidermal growth factor receptor ligands are chemoattractants for normal human mesothelial cells. Eur. Respir. J., 14: 405-411, 1999.
37. Murphy, G., and Gavrilovic, J. Proteolysis and cell migration: creating a path? Curr. Opin. Cell Biol., 11: 614-621, 1999.
38. Mercurio, A. M., and Rabinovitz, I. Towards a mechanistic understanding of tumor invasion: lessons from the α6β4 integrin. Semin. Cancer Biol., 11: 129-141, 2001.
39. Carloni, V., Mazzocca, A., Pantaleo, P., Cordella, C., Laffi, G., and Gentilini, P. The integrin, α6β1, is necessary for the matrix-dependent activation of FAK and MAP kinase and the migration of human hepatocarcinoma cells. Hepatology, 34: 42-49, 2001.
40. Cosgrove, D., Rodgers, K., Meehan, D., Miller, C., Bovard, K., Gilroy, A., Gardner, H., Kotelianski, V., Gotwals, P., Amatucci, A., and Kalluri, R. Integrin α1β1 and transforming growth factor-β1 play distinct roles in alport glomerular pathogenesis and serve as dual targets for metabolic therapy. Am. J. Pathol., 157: 1649-1659, 2000.
41. Ise, H., Sugihara, N., Negishi, N., Nikaido, T., and Akaike, T. Low asialoglycoprotein receptor expression as markers for highly proliferative potential hepatocytes. Biochem. Biophys. Res. Commun., 285: 172-182, 2001.
42. Hodgkinson, C. P., Wright, M. C., and Paine, A. J. Fibroneetin-mediated hepatocyte shape change reprograms cytochrome P450 2C11 gene expression via an integrin-signaled induction of ribonuclease activity. Mol. Pharmacol., 58: 976-981, 2000.
43. Yuan, S. T., Hu, X. Q., Lu, J. P., KeiKi, H., Zhai, W. R., and Zhang, Y. E. Changes of integrin expression in rat hepatocarcinogenesis induced by 3′-Me-DAB. World J. Gastroenterol., 6: 231-233, 2000.
44. Schaffert, C. S., Sorrell, M. F., and Tuma, D. J. Expression and cytoskeletal association of integrin subunits is selectively increased in rat perivenous hepatocytes after chronic ethanol administration. Alcohol. Clin. Exp. Res., 25: 1749-1757, 2001.
45. Kawakami-Kimura, N., Narita, T., Ohmori, K., Yoneda, T., Matsumoto, K., Nakamura, T., and Kannagi, R. Involvement of hepatocyte growth factor in increased integrin expression on HepG2 cells triggered by adhesion to endothelial cells. Br. J. Cancer, 75: 47-53, 1997.
46. Torimura, T., Ueno, T., Kin, M., Harad, R., Nakamura, T., Sakamoto, M., Kumashiro, R., Yano, H., Kojiro, M., and Sata, M. Laminin deposition to type IV collagen enhances haptotaxis, chemokinesis, and adhesion of hepatoma cells through β1-integrins. J. Hepatol., 35: 245-253, 2001.
47. Kagami, S., Kuhara, T., Yasutomo, K., Okada, K., Loster, K., Reutter, W., and Kuroda, Y. Transforming growth factor-β (TGF-β) stimulates the expression of β1 integrins and adhesion by rat mesangial cells. Exp. Cell Res., 229: 1-6, 1996.
48. Smida Rezgui, S., Honore, S., Rognoni, J. B., Martin, P. M., and Penel, C. Up-regulation of α2β1 integrin cell-surface expression protects A431 cells from epidermal growth factor-induced apoptosis. Int. J. Cancer, 87: 360-367, 2000.